← Browse by Condition
Medical Condition

refractory b cell lymphoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06378190 Phase 1, Phase 2
Recruiting

Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology

Enrollment
27 pts
Location
Spain
Sponsor
Instituto de Investigación Bio...
View Trial →